Antibody mediated rejection causing dialysis dependent acute renal failure,partially rescued with Eculizumab

摘要：

Antibody mediated rejection（ AMR） in transplant recipients may cause graft dysfunction and decreased graft survival1. Most of these patients have donor specific antibodies（ DSA）， C4d staining in peritubular capillaries and histological evidence of acute rejection on renal biopsy2. Current treatment options for AMR include plasma exchange（ PP）， intravenous immunoglobulin（ IVIG） and anti-CD 20 therapy3. Patients with severe forms of AMR usually do not respond to these treatments.

所属期刊栏目：6

在线出版日期：2018-09-19（万方平台首次上网日期，不代表论文的发表时间）

页数：共3页

页码：270-272